Kyparissia Sirinakis is a Managing Partner at Epidarex Capital. Ms. Sirinakis has more than 25 years of experience in creating and growing companies both as an early-stage venture investor and a senior executive in various technology and life science companies.

Prior to co-founding Epidarex Capital, she was part of the senior management team of MASA Life Science Ventures (MLSV) an early stage life science venture fund where she co-led the fund’s investment strategy and managed several MLSV portfolio investments through successful exits.  

Ms. Sirinakis was the Founder and Managing Director of LLC, a top performing fund investing in startup technology and healthcare companies in the Mid-Atlantic.   Ms. Sirinakis was the Chief Financial Officer of Oncologix, a venture-backed, early-stage biotechnology company based in Gaithersburg which was subsequently sold to Antigenics, Inc.  Ms. Sirinakis has extensive experience collaborating directly with numerous universities in the US and UK.   She also was previously the Director of a technology accelerator and Adjunct Professor at George Mason University.

Ms. Sirinakis is a frequent speaker on early stage investing and venture capital. She serves on the Board of the Tech Council of Maryland/MDBio, and on the Investment Committees for Virginia’s Center for Innovative Technology BioLife Fund and the Ivy Foundation.  She has held numerous directorships of start-up companies throughout her career and is currently on the Board of Harpoon Medical, Confluence Life Science and Sirakoss Ltd.  She is a graduate of Boston College’s School of Management Honors Program and a Certified Public Accountant in Maryland.

Fund's investment verticals:  life science and health technology.